OSCR
Oscar Health Inc
Oscar Health Inc historical holders
total: 5
Tiger Global Management Oscar Health Inc transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2021 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2022 Q2
Chase Coleman III has been an institutional investor in Oscar Health Inc (OSCR) since 2021 Q1. According to 2026 Q1 report, Chase Coleman III doesn't hold any shares. The fund/company first acquired OSCR in 2021 Q1, initially purchasing about 5.56M shares. Since the initial investment, Tiger Global Management has made 4 more transactions in this position.
When did Chase Coleman III exit their OSCR position?
Chase Coleman III no longer holds Oscar Health Inc (OSCR). They sold off their entire position in 2022 Q2, closing out an investment that began in 2021 Q1.
When did Chase Coleman III first invest in OSCR?
Chase Coleman III first invested in Oscar Health Inc (OSCR) in 2021 Q1 at the reported quarter-end price of $26.88 per share, acquiring 5,559,990 shares in their initial purchase.
What is Chase Coleman III's average cost basis for OSCR?
Based on historical transaction data, Chase Coleman III's estimated cost basis for Oscar Health Inc (OSCR) is approximately $24.75 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $24.75
- Weighted AVG sell price:
- $8.45
OSCR transactions history by Tiger Global Management
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q2
|
0.00%
|
0
|
$9.97
|
|
-100% (-2,127,454)
|
-0.08%
|
|
2021 Q4
|
0.04%
|
2,127,454
|
$7.85
|
$16,701,000
|
-71.69% (-5,387,113)
|
-0.08%
|
|
2021 Q3
|
0.25%
|
7,514,567
|
$17.39
|
$130,678,000
|
+21.61% (+1,335,158)
|
+0.04%
|
|
2021 Q2
|
0.25%
|
6,179,409
|
$21.50
|
$132,857,000
|
+11.14% (+619,419)
|
+0.02%
|
|
2021 Q1
|
0.34%
|
5,559,990
|
$26.88
|
$149,453,000
|
new
|
+0.34%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.